Comprehensive Case Challenges in MASH

Target Audience

The educational design of this activity addresses the needs of gastroenterology and hepatology specialists (MDs, nurse practitioners [NPs], physician associates [PAs], and other healthcare providers) involved in the management of patients with metabolic-associated steatohepatitis (MASH).

Program Overview

With the recent change in terminology to metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction–associated steatohepatitis (MASH) and the new cardiometabolic criteria, clinical practice has shifted to incorporate screening of more patients for MASLD/MASH. Employing noninvasive tests (NITs) is essential to identifying patients at high risk for MASH and further disease progression, as well as for selecting patients for the first-ever approved MASH therapy, resmetirom. Cardiometabolic comorbidities are common in these patients, and clinicians must be prepared to manage them, often using glucagon-like peptide-1 receptor agonists (GLP-1 RAs). In this case-based symposium, learners will be divided into teams and will compete to correctly answer clinical decision questions within each case. Each team will be led by our expert faculty, Drs. Vlad Ratziu and Rohit Loomba, with the didactic content presented as an explanation of the correct answer to each question. Topics covered will include nuances of diagnosis and staging using NITs, selecting candidates for resmetirom, and optimal management strategies, such as GLP-1 RAs, for the management of common cardiometabolic comorbidities. Join us for this fun, exciting, and competitive program and see if you have what it takes to win!

Educational Objectives

After completing this activity, the participant should be better able to:

1. Identify noninvasive tools that optimize diagnosis, staging, and monitoring of MASH
2. Develop treatment plans that incorporate recently approved and available therapies that target MASH and comorbid metabolic conditions
3. Describe recent advances and ongoing research in MASH diagnostics and pharmacologic treatment options

Physician Accreditation Statement

Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Continuing Medical Education

Integritas designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Integritas Contact Information

For more information about the approval of this program, please contact Integritas at info@exchangecme.com.